3D collagen high-throughput screen identifies drugs that induce epithelial polarity and enhance chemotherapy response in colorectal cancer
- Commun Biol. 2025 Aug 22;8(1):1261. doi: 10.1038/s42003-025-08699-0.
- 1. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- 2. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
- 3. Vanderbilt Institute of Chemical Biology, High-Throughput Screening Facility, Vanderbilt University, Nashville, TN, USA.
- 4. Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
- 5. Center for Computational Systems Biology, Vanderbilt University, Nashville, TN, USA.
- 6. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
- 7. Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
- 8. Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.
- 9. Department of Chemistry, Vanderbilt University, Nashville, TN, USA.
- 10. Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA.
- 11. Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
- 12. Vanderbilt-Cancer Ingram Center, Vanderbilt University Medical Center, Nashville, TN, USA.
- 13. Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
- 14. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. [email protected].
- 15. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA. [email protected].
- 16. Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, TN, USA. [email protected].
- 17. Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA. [email protected].
- 18. Vanderbilt-Cancer Ingram Center, Vanderbilt University Medical Center, Nashville, TN, USA. [email protected].
Loss of polarity is a hallmark of Cancer, and the related epithelial-to-mesenchymal transition (EMT) phenotype impacts prognosis and therapy outcomes, particularly in colorectal Cancer (CRC). However, the mechanisms and drugs that impact EMT-related morphological changes are understudied, due to the complete failure of typical live/dead 2D high-throughput screens to capture morphology or the lack of robustness of 3D screens. We designed a high-throughput screen using 3D type I Collagen cultures of CRC cells to assess morphological changes in colonies and identified several FDA-approved drugs that re-epithelialize CRC colonies. One of these drugs, azithromycin, increased colony circularity, enhanced E-cadherin membrane localization and ZO-1 localization to tight junctions, caused transcriptomic changes consistent with downregulation of EMT, and elevated sensitivity to the chemotherapeutic, irinotecan. A retrospective analysis of patient data demonstrated that the use of azithromycin in patients undergoing treatment for CRC with irinotecan had improved the 5 year survival compared to the chemotherapy alone. These results highlight the importance of morphological screens to identify novel drug candidates and synergistic mechanisms.
-
Cat. No.Product NameDescriptionTargetResearch Area
-